Stocks and Investing
Stocks and Investing
Fri, October 28, 2022
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
[ Fri, Oct 28th 2022
] - WOPRAI
Paul Knight Maintained (WST) at Buy with Decreased Target to $350 on, Oct 28th, 2022
Paul Knight of Keybanc, Maintained "West Pharmaceutical Services, Inc." (WST) at Buy with Decreased Target from $400 to $350 on, Oct 28th, 2022.
Paul has made no other calls on WST in the last 4 months.
There is 1 other peer that has a rating on WST. Out of the 1 peers that are also analyzing WST, all agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jacob Johnson of "Stephens & Co." Maintained at Hold with Increased Target to $345 on, Friday, July 29th, 2022
Contributing Sources